Showing results 1 to 20 of 31
next >
Issue Date | Title | Author(s) |
2011 | Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia | Niu, Jihong; Li, Henan; Zhang, Yao; Li, Jinlan; Xie, Min; Li, Lingdi; Qin, Xiaoying; Qin, Yazhen; Guo, Xiaohuan; Jiang, Qian; Liu, Yanrong; Chen, Shanshan; Huang, Xiaojun; Han, Wenling; Ruan, Guorui |
5-Mar-2024 | Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome-positive acute lymphoblastic leukaemia | Hu, Lijuan; Li, Zongru; Yang, Sen; Zhao, Ting; Duan, Wenbing; Qin, Yazhen; Jia, Jinsong; Wang, Jing; Lu, Shengye; Jiang, Hao; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Lai, Yueyun; Shi, Hongxia; Huang, Xiaojun; Jiang, Qian |
2016 | Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China | Lu, Jin; Hou, Jian; Liu, Kai-Yan; Parmar, Simrit; De La Fuente, Adolfo; Andersson, Borje; Yan, ChenHua; Zhou, Daobin; Tan, Daryl; Ritchie, David; Wu, Deipei; Shpall, Elizabeth; Laport, Ginna G.; Li, JianYong; Hu, Jiong; Zhang, Lian Sheng; Wang, Michael; Malhotra, Pankaj; Jiang, Qian; Qin, Yazhen; Wong, Raymond; Champlin, Richard; Issaragrisil, Surapol; Iyer, Swaminathan; Mathews, Vikram; Wang, Yu; Hu, Yu; Xiao, Zhijian; Shao, Zonghong; Rosengarten, Rafael; Steuernagle, Jon; Xiao, Jun Huang; Orlowski, Robert; Chim, Chor Sang |
2019 | Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors | Ren, Xin; Qin, Yazhen; Huang, Xiaojun; Zuo, Li; Jiang, Qian |
Jan-2021 | Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center | Duan, Wenbing; Liu, Xiaohong; Zhao, Xiaosu; Jia, Jinsong; Wang, Jing; Gong, Lizhong; Jiang, Qian; Zhao, Ting; Wang, Yu; Zhang, Xiaohui; Xu, Lanping; Shi, Hongxia; Chang, Yingjun; Liu, Kaiyan; Huang, Xiaojun; Qin, Yazhen; Jiang, Hao |
2012 | CD34 Expression On the Blasts of Bone Marrow Is a Novel Predictor of Poor Prognosis Independent of FlT3-ITD in Acute Myeloid Leukemia with NPM1-Mutation | Zhu, Hong-Hu; Liu, Yan-Rong; Jiang, Hao; Lu, Jin; Qin, Yazhen; Jiang, Qian; Huang, Xiaojun |
2018 | Classifying AML Patients with Inv(16) into High-Risk and Low-Risk Released Patients Based on Peritransplantation Minimal Residual Disease Determined By CBF(I)over-cap(2)/MYH11 Gene Expression | Zhao, Xiaosu; Cao, Leqing; Qin, Yazhen; Zhang, Xiaohui; Xu, Lanping; Huang, Xiaojun; Chang, Ying-Jun |
2013 | Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity | Zhao, Xiaosu; Yan, Chenhua; Liu, Daihong; Xu, Lanping; Liu, Yanrong; Liu, Kaiyan; Qin, Yazhen; Wang, Yu; Huang, Xiaojun |
2012 | Combined Use of WT1 and Flow Cytometry Monitoring Can Promote Sensitivity of Predicting Relapse After Allogeneic HSCT without Affecting Specificity. | Zhao, Xiaosu; Yan, Chenhua; Liu, Daihong; Xu, Lanping; Liu, Yanrong; Liu, Kaiyan; Qin, Yazhen; Wang, Yu; Huang, Xiaojun |
Jun-2020 | Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center | Dou, Xuelin; Qin, Yazhen; Lai, Yueyun; Shi, Hongxia; Huang, Xiaojun; Jiang, Qian |
Jan-2021 | Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center (vol 20, pg e304, 2020) | Dou, Xuelin; Qin, Yazhen; Lai, Yueyun; Shi, Hongxia; Huang, Xiaojun; Jiang, Qian |
2018 | Comparative analysis of flow cytometry and RQ-PCR for the detection of minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia after hematopoietic stem cell transplantation | Zhao, Xiangyu; Zhao, Xiaosu; Chen, Huan; Qin, Yazhen; Xu, Lanping; Zhang, Xiaohui; Liu, Kaiyan; Huang, Xiaojun; Chang, Yingjun |
2018 | Comparative analysis of flow cytometry and RQ-PCR for the detection of minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia after hematopoietic stem cell transplantation | Zhao, Xiangyu; Zhao, Xiaosu; Chen, Huan; Qin, Yazhen; Xu, Lanping; Zhang, Xiaohui; Liu, Kaiyan; Huang, Xiaojun; Chang, Yingjun |
2023 | Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia | Duan, Wenbing; Yang, Sen; Zhao, Ting; Hu, Lijuan; Qin, Yazhen; Jia, Jinsong; Wang, Jing; Lu, Shengye; Jiang, Hao; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Lai, Yueyun; Shi, Hongxia; Huang, Xiaojun; Jiang, Qian |
23-Nov-2021 | Correlations between Mutations in Cancer -Related Genes, Therapy Responses and Outcomes of the 3 (rd) Generation Tyrosine Kinase-Inhibitor (TKI) in Persons with Chronic Myeloid Leukemia Failing Prior TKI-Therapy | Zhang, Xiaoshuai; Li, Zongru; Qin, Yazhen; Gale, Robert Peter; Huang, Xiaojun; Jiang, Qian |
2015 | CTLA-4 Polymorphisms and Haplotype Correlate with Survival and aGVHD after Allogeneic Stem Cell Transplantation from Related HLA-Haplotype-Mismatched Donor | Qin, Xiao-Ying; Wang, Yu; Li, Guo-Xuan; Qin, Yazhen; Xu, Lan-Ping; Wang, Fengrong; Chen, Huan; Han, Wei; Wang, Jing-Zhi; Zhang, Xiao-Hui; Chang, Ying-jun; Liu, Kaiyan; Jiang, Zheng-Fan; Huang, Xiao-Jun |
2015 | CTLA-4 Polymorphisms and Haplotype Correlate with Survival and aGVHD after Allogeneic Stem Cell Transplantation from Related HLA-Haplotype-Mismatched Donor | Qin, Xiao-Ying; Wang, Yu; Li, Guo-Xuan; Qin, Yazhen; Xu, Lan-Ping; Wang, Fengrong; Chen, Huan; Han, Wei; Wang, Jing-Zhi; Zhang, Xiao-Hui; Chang, Ying-jun; Liu, Kaiyan; Jiang, Zheng-Fan; Huang, Xiao-Jun |
2013 | CXCR4 is a good survival prognostic indicator in multiple myeloma patients | Bao, Li; Lai, Yueyun; Liu, Yanrong; Qin, Yazhen; Zhao, Xiaosu; Lu, Xijing; Jiang, Qian; Lu, Jin; Huang, Xiaojun |
May-2024 | Cytoreductive chemotherapy in induction therapy plays a key role in the prognosis of patients with low-risk acute promyelocytic leukaemia | Zhu, Xiaolu; Tang, Feifei; Yu, Wenjing; Zhao, Xiaosu; Qin, Yazhen; Jiang, Qian; Huang, Xiaojun; Jiang, Hao |
2-Nov-2023 | Cytoreductive Chemotherapy in Induction Therapy Plays a Key Role in the Prognosis of Patients with Low-Risk Acute Promyelocytic Leukemia | Zhu, Xiaolu; Tang, Feifei; Yu, Wenjing; Zhao, Xiaosu; Qin, Yazhen; Jiang, Qian; Huang, Xiao Jun; Jiang, Hao |